Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × zilucoplan × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Radiotherapy 292 Specimen Handling 291 Magnetic Resonance Spectroscopy 289 pembrolizumab 272 Cyclophosphamide 258 Cisplatin 234 Carboplatin 217 Blood Specimen Collection 214 Drug Therapy 204 Biopsy 176 Gemcitabine 161 venetoclax 157 Bevacizumab 157 Radiosurgery 152 fludarabine 143 Oxaliplatin 143 Capecitabine 140 Nivolumab 139 Paclitaxel 134 Standard of Care 124 Surgical Procedures, Operative 120 Fluorouracil 115 Dexamethasone 113 Surveys and Questionnaires 112 Docetaxel 102 Rituximab 99 tislelizumab 98 Radiation 98 Cytarabine 95 durvalumab 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Ohio State University

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡